UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma

Annals of oncology, 2016-08, Vol.27 (8), p.1467-1474

2016

Volltextzugriff (PDF)

Chronic Hepatitis E in Heart Transplant Recipients

American journal of transplantation, 2012-11, Vol.12 (11), p.3128-3133

2012

Volltextzugriff (PDF)

Predictors of nosocomial spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis and ascites

Journal of hepatology, 2017, Vol.66 (1), p.S578-S579

2017

Volltextzugriff (PDF)

New GLP-1 agonist dulaglutide improves metabolic dysfunction and extenuates development of non-acoholic steatohepatitis in mice

Journal of hepatology, 2017, Vol.66 (1), p.S432-S433

2017

Volltextzugriff (PDF)

Proton pump inhibitors are associated with a higher risk for spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites

Journal of hepatology, 2017, Vol.66 (1), p.S578-S578

2017

Volltextzugriff (PDF)

Retargeting of anti-viral immune responses to solid tumors using bispecific adapters

European journal of cancer (1990), 2016-07, Vol.61, p.S123-S123

2016

Volltextzugriff (PDF)

686: microRNAs in hepatocellular carcinoma

European journal of cancer (1990), 2014-07, Vol.50, p.S165-S165

2014

Volltextzugriff (PDF)

902 LONG-TERM FOLLOW UP OF 100 PATIENTS WITH POLYCYSTIC LIVER DISEASE – EFFICACY OF PERCUTANEOUS US-GUIDED POLIDOCANOL SCLEROTHERAPY

Journal of hepatology, 2011-03, Vol.54, p.S359-S359

2011

Volltextzugriff (PDF)

P396 PREDICTION OF SHORT- AND LONG-TERM OUTCOME IN PATIENTS WITH AUTOIMMUNE HEPATITIS

Journal of hepatology, 2014-04, Vol.60 (1), p.S200-S200

2014

Volltextzugriff (PDF)

P0324 : EpCAM cleaved extracellular domain has profound effect on human progenitor cell line HepaRG, but barely effects hepatocarcinoma cell line HepG2

Journal of hepatology, 2015-04, Vol.62, p.S430-S430

2015

Volltextzugriff (PDF)

P1151 : Genetic variants of UDP-glucuronosyltransferase (UGT) 1A genes modify the presentation and disease progression in patients with primary sclerosing cholangitis

Journal of hepatology, 2015-04, Vol.62, p.S784-S785

2015

Volltextzugriff (PDF)

P0051 : Perioperative white blood cell count as a marker for patient and graft survival after orthotopic liver transplantation

Journal of hepatology, 2015-04, Vol.62, p.S311-S311

2015

Volltextzugriff (PDF)

P0073 : Individualizing hbig reinfection prophylaxis after HBV-induced liver transplantation: Results from a mathematical modeling approach based on clinical data

Journal of hepatology, 2015-04, Vol.62, p.S320-S320

2015

Volltextzugriff (PDF)

Hepatitis E ORF2 Antigen Levels Differentiate between Acute and Chronic Course of Infection

Journal of hepatology, 2016, Vol.64 (2), p.S375-S375

2016

Volltextzugriff (PDF)

The Addition of Ribavirin is Associated with a Significantly Reduced Quality of Life in Patients Treated with IFN-Free Direct-Acting Antiviral Therapy

Journal of hepatology, 2016, Vol.64 (2), p.S611-S611

2016

Volltextzugriff (PDF)

DAA-Induced HCV Clearance does not Restore the Altered Cytokine and Chemokine Milieu in Patients with Chronic Hepatitis C

Journal of hepatology, 2016, Vol.64 (2), p.S417-S418

2016

Volltextzugriff (PDF)

Microrna-221 Inhibition in Hepatocytes: A Novel Strategy to Treat Liver Fibrosis

Journal of hepatology, 2016, Vol.64 (2), p.S707-S708

2016

Volltextzugriff (PDF)

Small Molecule FPH2 Mediates Long-Term Hepatocyte Expansion in Vitro and Induces Liver Regeneration in Mice

Journal of hepatology, 2016, Vol.64 (2), p.S349-S349

2016

Volltextzugriff (PDF)

Pediatric autoimmune hepatitis shows a strong increase of intrahepatic Tregs and an IL-2 associated Treg decline under therapy

Journal of hepatology, 2017, Vol.66 (1), p.S367-S367

2017

Volltextzugriff (PDF)

Delayed decrease of splenic stiffness in chronic hepatitis C virus patients receiving direct-acting antivirals

Journal of hepatology, 2017, Vol.66 (1), p.S236-S236

2017

Volltextzugriff (PDF)

Interferon-free therapy of chronic hepatitis C does not change the short-term risk for de novo hepatocellular carcinomas in patients with liver cirrhosis

Journal of hepatology, 2017, Vol.66 (1), p.S210-S211

2017

Volltextzugriff (PDF)

Whole genome deep sequencing is superior to sequencing only regions of special interest for the characterization of HDV evolution

Journal of hepatology, 2017, Vol.66 (1), p.S485-S485

2017

Volltextzugriff (PDF)

A phase 2 dose-escalation study of lonafarnib plus ritonavir in patients with chronic hepatitis D: final results from the Lonafarnib with ritonavir in HDV-4 (LOWR HDV-4) study

Journal of hepatology, 2017, Vol.66 (1), p.S24-S24

2017

Volltextzugriff (PDF)

Hepatitis E virus-specific T cell responses against non-structural viral proteins in patients with ongoing and resolved hepatitis E

Journal of hepatology, 2017, Vol.66 (1), p.S537-S538

2017

Volltextzugriff (PDF)

Interferon-free cure of hepatitis C virus infection does alter the soluble inflammatory milieu which could affect hepatocellular carcinoma surveillance by CD8+ T cells in patients with liver cirrhosis

Journal of hepatology, 2017, Vol.66 (1), p.S2-S2

2017

Volltextzugriff (PDF)

1 – 25 von 594

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(553)
Mit Volltextzugriff
(580)

Publikationsform

Sprache

Englisch
(561)
Deutsch
(34)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma

Chronic Hepatitis E in Heart Transplant Recipients

Predictors of nosocomial spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis and ascites

New GLP-1 agonist dulaglutide improves metabolic dysfunction and extenuates development of non-acoholic steatohepatitis in mice

Proton pump inhibitors are associated with a higher risk for spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites

Retargeting of anti-viral immune responses to solid tumors using bispecific adapters

686: microRNAs in hepatocellular carcinoma

902 LONG-TERM FOLLOW UP OF 100 PATIENTS WITH POLYCYSTIC LIVER DISEASE – EFFICACY OF PERCUTANEOUS US-GUIDED POLIDOCANOL SCLEROTHERAPY

P396 PREDICTION OF SHORT- AND LONG-TERM OUTCOME IN PATIENTS WITH AUTOIMMUNE HEPATITIS

P0324 : EpCAM cleaved extracellular domain has profound effect on human progenitor cell line HepaRG, but barely effects hepatocarcinoma cell line HepG2

P1151 : Genetic variants of UDP-glucuronosyltransferase (UGT) 1A genes modify the presentation and disease progression in patients with primary sclerosing cholangitis

P0051 : Perioperative white blood cell count as a marker for patient and graft survival after orthotopic liver transplantation

P0073 : Individualizing hbig reinfection prophylaxis after HBV-induced liver transplantation: Results from a mathematical modeling approach based on clinical data

Hepatitis E ORF2 Antigen Levels Differentiate between Acute and Chronic Course of Infection

The Addition of Ribavirin is Associated with a Significantly Reduced Quality of Life in Patients Treated with IFN-Free Direct-Acting Antiviral Therapy

DAA-Induced HCV Clearance does not Restore the Altered Cytokine and Chemokine Milieu in Patients with Chronic Hepatitis C

Microrna-221 Inhibition in Hepatocytes: A Novel Strategy to Treat Liver Fibrosis

Small Molecule FPH2 Mediates Long-Term Hepatocyte Expansion in Vitro and Induces Liver Regeneration in Mice

Pediatric autoimmune hepatitis shows a strong increase of intrahepatic Tregs and an IL-2 associated Treg decline under therapy

Delayed decrease of splenic stiffness in chronic hepatitis C virus patients receiving direct-acting antivirals

Interferon-free therapy of chronic hepatitis C does not change the short-term risk for de novo hepatocellular carcinomas in patients with liver cirrhosis

Whole genome deep sequencing is superior to sequencing only regions of special interest for the characterization of HDV evolution

A phase 2 dose-escalation study of lonafarnib plus ritonavir in patients with chronic hepatitis D: final results from the Lonafarnib with ritonavir in HDV-4 (LOWR HDV-4) study

Hepatitis E virus-specific T cell responses against non-structural viral proteins in patients with ongoing and resolved hepatitis E

Interferon-free cure of hepatitis C virus infection does alter the soluble inflammatory milieu which could affect hepatocellular carcinoma surveillance by CD8+ T cells in patients with liver cirrhosis

Suchergebnisse filtern